Matthew has extensive experience in negotiating and drafting agreements for the development, licensing, production, supply, and support of semiconductors and other hardware; software and data; pharmaceutical, biotechnology, and medical devices and systems; and multimedia and entertainment products and content. He has negotiated agreements for the protection and transfer of copyrights, trademarks, patents, trade secrets, and other intellectual property, and has litigated copyright, trademark, patent, trade secret, royalty, and domain name claims and disputes.
In addition, Matthew represents technology, life sciences, and media and entertainment companies in financings, mergers and acquisitions, strategic alliances, and joint ventures, and other corporate structuring matters. He also represents emerging technology companies and ventures in entity formation, and is experienced in structuring and negotiating angel and venture financing.
Matthew has particular experience in the semiconductor and computer hardware area. He has advised clients with regard to, and has negotiated and drafted agreements for, the development and licensing of semiconductor process technology and cores, SIP, and other semiconductor designs; the purchase and sale of semiconductor tooling and equipment; the manufacturing, packaging and testing, distribution, sale, and other commercialization of semiconductor products; and the manufacturing, assembly, testing, distribution, sale, and other commercialization of servers, personal computers, handheld devices, and other hardware. Matthew has also advised clients with regard to, and has negotiated and drafted agreements for, mergers and acquisitions of semiconductor and other hardware companies and joint ventures for the development of semiconductor process technology and designs, the construction of fabs, the manufacturing of semiconductor products, the design, development, manufacturing and assembly, distribution, and sale of servers and other types of computers, and the design, development, manufacturing, distribution, and sale of high-end switches and routers.
Matthew is recognized as a recommended licensing expert in Intellectual Asset Management’s inaugural edition of the IAM Patent 1000, and has been recognized for excellence in the area of life sciences by Intellectual Asset Management’s IAM Licensing 250 rankings.